CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ABBV — AbbVie Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,820,279,389
-$2,930,778,265 QoQ
Shares Held
12,967,398
-48.5% QoQ
Ownership
0.734%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.43876944318359.ToString("F0")%
Shared 0.ToString("F0")%
None 0.5612305568164099.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $30,098,800,763 across 16 Drug Manufacturers - General names. ABBV ranks #6 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
49,765,225 | $5,986,258,914 | |
| 2 | LLY |
ELI LILLY & Co
|
5,897,450 | $5,424,297,586 | |
| 3 | JNJ |
Johnson & Johnson
|
19,177,219 | $4,687,679,411 | |
| 4 | AMGN |
Amgen Inc
|
12,773,386 | $4,494,315,864 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
61,115,373 | $3,706,647,372 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
12,967,398 | $2,820,279,389 | |
| 7 | PFE |
Pfizer Inc
|
51,891,636 | $1,457,117,138 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,181,780 | $1,140,294,678 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,820,279,389 | 12,967,398 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,751,057,654 | 25,169,844 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,010,339,861 | 25,958,106 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $4,971,521,527 | 26,783,329 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,293,299,030 | 25,263,932 | Shares | Other | 2025-09-15 | |
| 2024-12-31 | $4,875,400,833 | 27,436,133 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,707,290,670 | 23,836,797 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $4,283,639,446 | 24,974,577 | Shares | Other | 2024-08-12 | |
| 2024-03-31 | $4,136,822,879 | 22,717,314 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,789,322,565 | 24,451,975 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,391,049,413 | 22,749,560 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,071,446,815 | 22,797,052 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,432,296,866 | 21,536,656 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,457,869,588 | 9,020,912 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,197,093,879 | 8,919,558 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,350,589,845 | 8,818,163 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,443,587,604 | 8,904,988 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,181,901,454 | 8,728,962 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $922,934,641 | 8,555,990 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $959,841,597 | 8,521,321 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $911,390,205 | 8,421,643 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $872,819,898 | 8,145,776 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $711,993,971 | 8,128,713 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $830,470,551 | 8,458,653 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $536,092,116 | 7,036,253 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||